Dietary and pharmacologic regimens to reduce lipid peroxidation in non- insulin-dependent diabetes mellitus

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Persons with diabetes are at increased risk for developing coronary heart disease (CHD): although the standard risk factors are also applicable, there are other major nontraditional risk factors for these persons. For example, oxidation of lipoproteins may play an important role in the development of atherosclerosis. Another risk factor is the presence of small, dense low- density lipoprotein (LDL), which may have enhanced atherogenicity because it enters the arterial wall more readily and is more easily oxidized. Both of these factors may be particularly, important in persons with non-insulin- dependent diabetes mellitus (NIDDM), because these persons may have greater rates of lipid oxidation in vivo than do nondiabetic persons and also have an increased prevalence of small, dense LDL. I describe potential dietary and pharmacologic regimens in patients with NIDDM to decrease in vivo lipid peroxidation, and the susceptibility of LDL and dense LDL subfractions to oxidative modification. In nearly all NIDDM patients, reducing dietary saturated fat helps lower plasma cholesterol and reduces the risk for CHD. There is, however, some controversy as to whether dietary saturated fat should be replaced by carbohydrates or by monounsaturated fatty acids (MUFAs) in NIDDM. Recent studies showed reduced susceptibility to oxidation of LDL in subjects consuming MUFA-enriched diets, thus adding another dimension to the ongoing debate over the most appropriate diet for NIDDM patients. Additionally, supplemental antioxidants such as probucol and vitamin E alone or tit combination with MUFA-enriched diets have shown promise in protecting LDL from oxidation when given to nondiabetic populations. I also present recent results from an antioxidant trial in NIDDM subjects.

Original languageEnglish (US)
Pages (from-to)1483S-1489S
JournalAmerican Journal of Clinical Nutrition
Volume62
Issue number6 SUPPL.
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

LDL Lipoproteins
Type 2 Diabetes Mellitus
Lipid Peroxidation
Monounsaturated Fatty Acids
Dietary Fats
Diet
Coronary Disease
Antioxidants
Probucol
Vitamin E
Lipoproteins
Atherosclerosis
Cholesterol
Carbohydrates
Lipids
Population

Keywords

  • glycosylation
  • Lipid peroxidation
  • low-density lipoproteins
  • monounsaturated fatty acids
  • non-insulin-dependent diabetes mellitus
  • small dense LDL
  • vitamin E

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Dietary and pharmacologic regimens to reduce lipid peroxidation in non- insulin-dependent diabetes mellitus. / Reaven, P.

In: American Journal of Clinical Nutrition, Vol. 62, No. 6 SUPPL., 01.01.1995, p. 1483S-1489S.

Research output: Contribution to journalArticle

@article{53e8d9571d72479685dbaa1388fbc3d1,
title = "Dietary and pharmacologic regimens to reduce lipid peroxidation in non- insulin-dependent diabetes mellitus",
abstract = "Persons with diabetes are at increased risk for developing coronary heart disease (CHD): although the standard risk factors are also applicable, there are other major nontraditional risk factors for these persons. For example, oxidation of lipoproteins may play an important role in the development of atherosclerosis. Another risk factor is the presence of small, dense low- density lipoprotein (LDL), which may have enhanced atherogenicity because it enters the arterial wall more readily and is more easily oxidized. Both of these factors may be particularly, important in persons with non-insulin- dependent diabetes mellitus (NIDDM), because these persons may have greater rates of lipid oxidation in vivo than do nondiabetic persons and also have an increased prevalence of small, dense LDL. I describe potential dietary and pharmacologic regimens in patients with NIDDM to decrease in vivo lipid peroxidation, and the susceptibility of LDL and dense LDL subfractions to oxidative modification. In nearly all NIDDM patients, reducing dietary saturated fat helps lower plasma cholesterol and reduces the risk for CHD. There is, however, some controversy as to whether dietary saturated fat should be replaced by carbohydrates or by monounsaturated fatty acids (MUFAs) in NIDDM. Recent studies showed reduced susceptibility to oxidation of LDL in subjects consuming MUFA-enriched diets, thus adding another dimension to the ongoing debate over the most appropriate diet for NIDDM patients. Additionally, supplemental antioxidants such as probucol and vitamin E alone or tit combination with MUFA-enriched diets have shown promise in protecting LDL from oxidation when given to nondiabetic populations. I also present recent results from an antioxidant trial in NIDDM subjects.",
keywords = "glycosylation, Lipid peroxidation, low-density lipoproteins, monounsaturated fatty acids, non-insulin-dependent diabetes mellitus, small dense LDL, vitamin E",
author = "P. Reaven",
year = "1995",
month = "1",
day = "1",
doi = "10.1093/ajcn/62.6.1483S",
language = "English (US)",
volume = "62",
pages = "1483S--1489S",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "6 SUPPL.",

}

TY - JOUR

T1 - Dietary and pharmacologic regimens to reduce lipid peroxidation in non- insulin-dependent diabetes mellitus

AU - Reaven, P.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Persons with diabetes are at increased risk for developing coronary heart disease (CHD): although the standard risk factors are also applicable, there are other major nontraditional risk factors for these persons. For example, oxidation of lipoproteins may play an important role in the development of atherosclerosis. Another risk factor is the presence of small, dense low- density lipoprotein (LDL), which may have enhanced atherogenicity because it enters the arterial wall more readily and is more easily oxidized. Both of these factors may be particularly, important in persons with non-insulin- dependent diabetes mellitus (NIDDM), because these persons may have greater rates of lipid oxidation in vivo than do nondiabetic persons and also have an increased prevalence of small, dense LDL. I describe potential dietary and pharmacologic regimens in patients with NIDDM to decrease in vivo lipid peroxidation, and the susceptibility of LDL and dense LDL subfractions to oxidative modification. In nearly all NIDDM patients, reducing dietary saturated fat helps lower plasma cholesterol and reduces the risk for CHD. There is, however, some controversy as to whether dietary saturated fat should be replaced by carbohydrates or by monounsaturated fatty acids (MUFAs) in NIDDM. Recent studies showed reduced susceptibility to oxidation of LDL in subjects consuming MUFA-enriched diets, thus adding another dimension to the ongoing debate over the most appropriate diet for NIDDM patients. Additionally, supplemental antioxidants such as probucol and vitamin E alone or tit combination with MUFA-enriched diets have shown promise in protecting LDL from oxidation when given to nondiabetic populations. I also present recent results from an antioxidant trial in NIDDM subjects.

AB - Persons with diabetes are at increased risk for developing coronary heart disease (CHD): although the standard risk factors are also applicable, there are other major nontraditional risk factors for these persons. For example, oxidation of lipoproteins may play an important role in the development of atherosclerosis. Another risk factor is the presence of small, dense low- density lipoprotein (LDL), which may have enhanced atherogenicity because it enters the arterial wall more readily and is more easily oxidized. Both of these factors may be particularly, important in persons with non-insulin- dependent diabetes mellitus (NIDDM), because these persons may have greater rates of lipid oxidation in vivo than do nondiabetic persons and also have an increased prevalence of small, dense LDL. I describe potential dietary and pharmacologic regimens in patients with NIDDM to decrease in vivo lipid peroxidation, and the susceptibility of LDL and dense LDL subfractions to oxidative modification. In nearly all NIDDM patients, reducing dietary saturated fat helps lower plasma cholesterol and reduces the risk for CHD. There is, however, some controversy as to whether dietary saturated fat should be replaced by carbohydrates or by monounsaturated fatty acids (MUFAs) in NIDDM. Recent studies showed reduced susceptibility to oxidation of LDL in subjects consuming MUFA-enriched diets, thus adding another dimension to the ongoing debate over the most appropriate diet for NIDDM patients. Additionally, supplemental antioxidants such as probucol and vitamin E alone or tit combination with MUFA-enriched diets have shown promise in protecting LDL from oxidation when given to nondiabetic populations. I also present recent results from an antioxidant trial in NIDDM subjects.

KW - glycosylation

KW - Lipid peroxidation

KW - low-density lipoproteins

KW - monounsaturated fatty acids

KW - non-insulin-dependent diabetes mellitus

KW - small dense LDL

KW - vitamin E

UR - http://www.scopus.com/inward/record.url?scp=0028847091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028847091&partnerID=8YFLogxK

U2 - 10.1093/ajcn/62.6.1483S

DO - 10.1093/ajcn/62.6.1483S

M3 - Article

C2 - 7495249

AN - SCOPUS:0028847091

VL - 62

SP - 1483S-1489S

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 6 SUPPL.

ER -